 |
PDBsum entry 1yu6
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
Chains A, B:
E.C.3.4.21.62
- subtilisin.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Hydrolysis of proteins with broad specificity for peptide bonds, and a preference for a large uncharged residue in P1. Hydrolyzes peptide amides.
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Acta Crystallogr D Biol Crystallogr
61:580-588
(2005)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structure of the subtilisin Carlsberg-OMTKY3 complex reveals two different ovomucoid conformations.
|
|
J.T.Maynes,
M.M.Cherney,
M.A.Qasim,
M.Laskowski,
M.N.James.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
One of the most studied protein proteinase inhibitors is the turkey ovomucoid
third domain, OMTKY3. This inhibitor contains a reactive-site loop
(Lys13I-Arg21I) that binds in a nearly identical manner to all studied serine
proteinases, regardless of their clan or specificity. The crystal structure of
OMTKY3 bound to subtilisin Carlsberg (CARL) has been determined. There are two
complete copies of the complexes in the crystallographic asymmetric unit.
Whereas the two enzyme molecules are virtually identical [0.16 A
root-mean-square difference (r.m.s.d.) for 274 C(alpha) atoms], the two
inhibitor molecules show dramatic differences between one another (r.m.s.d. =
2.4 A for 50 C(alpha) atoms). When compared with other proteinase-bound OMTKY3
molecules, these inhibitors show even larger differences. This work facilitates
a re-evaluation of the importance of certain ovomucoid residues in proteinase
binding and explains why additivity and sequence-based binding-prediction
methods fail for the CARL-OMTKY3 complex.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 3.
Figure 3
(a) Active-site representation of one of the CARL-OMKTY3 complexes in the asymmetric unit.
C atoms for the CARL structure are colored orange and for OMTKY3 are colored grey.
Labelling for pertinent residues follows a similar coloring scheme. Water molecules are
shown as green spheres and hydrogen-bonding interactions are shown as dashed lines. (b)
Active-site representation of the second complex of CARL-OMTKY3 present in the asymmetric
unit. Coloring is as in (a). (c) Representative electron density shown in stereo for the
catalytic triad of subtilisin (Asp32, His64 and Ser221) and the P[2] (Thr17I), P[1]
(Leu18I) and [134][{\rm P}'_{1}] (Glu19I) residues of the ovomucoid inhibitor. The map
shown is a [135][sigma] [A]-weighted 2|F[o]| - |F[c]| map ( [136][alpha] [calc]) contoured
at 1 [137][sigma] .
|
 |
Figure 4.
Figure 4
Overlay of the complex between CARL-OMTKY3 and CARL-eglin c (PDB code [208]1cse ). The
CARL-OMTKY3 complex is shown with orange (CARL) and blue (OMKTY) C atoms. The CARL-eglin c
complex is shown with green (CARL) and yellow (eglin c) C atoms. The sequence of OMKTY3 in
this region is P[2]-Thr-Leu-Glu- [209][{\rm P}'_{1}] and for eglin c the sequence is
P[2]-Thr-Leu-Asp- [210][{\rm P}'_{1}] . Potential hydrogen bonds are shown as dashed
lines.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the IUCr:
Acta Crystallogr D Biol Crystallogr
(2005,
61,
580-588)
copyright 2005.
|
|
| |
Figures were
selected
by the author.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
V.Martínek,
J.Sklenár,
M.Dracínsky,
M.Sulc,
K.Hofbauerová,
K.Bezouska,
E.Frei,
and
M.Stiborová
(2010).
Glycosylation protects proteins against free radicals generated from toxic xenobiotics.
|
| |
Toxicol Sci,
117,
359-374.
|
 |
|
|
|
|
 |
Y.González,
T.Pons,
J.Gil,
V.Besada,
M.Alonso-del-Rivero,
A.S.Tanaka,
M.S.Araujo,
and
M.A.Chávez
(2007).
Characterization and comparative 3D modeling of CmPI-II, a novel 'non-classical' Kazal-type inhibitor from the marine snail Cenchritis muricatus (Mollusca).
|
| |
Biol Chem,
388,
1183-1194.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
|
');
}
}
 |
|